ARCHIVES

RFA On Promoters, Hormones, Other Cofactors Available

This article is from The Cancer Letter archive.

Vol. 07 No. 29 | July 17, 1981

Download PDF Visit The Full Archive

Related Articles

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

NCI Approved Clinical Trials

May 28, 2010

NCI’s Justification For 1981 Budget

June 8, 1979

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

Toxicology Program Seeks Comment On Substances.

March 23, 2001